DCGI panel backs nod for India’s 1st flu shot from Cadila

The committee met in the last week of November and deliberated on the phase-3 clinical trials report submitted by the firm.

from mint - Science https://ift.tt/LdEjfZO
https://ift.tt/czbxZRB